We’ve been waiting patiently for results of the Harvard/Mass General Hospital study assessing the efficacy of NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) in alleviating symptoms associated with “long haul COVID”. Well, the results are finally here.
Month: November 2025
Many are anxiously awaiting results of clinical trials testing NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes). During yesterday’s earnings call, Niagen Bioscience CEO Rob Fried provided the following update:
During the presentation portion of yesterdays’s earnings call, Niagen Bioscience CEO Rob Fried said the following:
A recent Fox News article correctly points out that the NAD+ molecule is too large to get into cells: